Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
263.38
+2.19 (+0.84%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
48
49
Next >
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
April 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Regulatory Compliance
Exposures
Financial
Legal
Regulatory
1 Dividend Growth Stock to Buy Hand Over Fist
March 31, 2023
Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time.
Via
The Motley Fool
Amgen's Debt Overview
March 31, 2023
Via
Benzinga
A Look Into Amgen Inc's Price Over Earnings
March 30, 2023
Via
Benzinga
Amgen Options Traders Betting On Stock Rising This Much By April Expiration
March 30, 2023
Within the next month, Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.
Via
Benzinga
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
March 30, 2023
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.
Via
The Motley Fool
Looking At Amgen's Recent Unusual Options Activity
March 20, 2023
Via
Benzinga
The Government Move That Could Drive Obesity Drugs — And Lilly, Novo Shares
March 29, 2023
The decision from the WHO could further bolster use of Novo's Saxenda and Wegovy.
Via
Investor's Business Daily
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
March 29, 2023
Viking Therapeutics stock might in the midst of a historic run.
Via
The Motley Fool
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
March 28, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Regulatory Compliance
Exposures
Financial
Legal
Regulatory
Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says
March 28, 2023
Earlier today, Viking Therapeutics Inc (NASDAQ: VKTX) announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735.
Via
Benzinga
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
March 28, 2023
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP
Via
MarketBeat
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm
March 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
March 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amgen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
March 25, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Regulatory Compliance
Exposures
Financial
Legal
Regulatory
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
March 24, 2023
The company is working on an oral version of its cult-following injection, Ozempic.
Via
Investor's Business Daily
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
March 22, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
March 22, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Nvidia's Artificial Intelligence Market Strategy Impresses Wall Street
March 22, 2023
Analysts on Wednesday praised Nvidia's approach to artificial intelligence as it moves deeper into software and services. NVDA stock rose.
Via
Investor's Business Daily
Amgen Inc. (AMGN) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Amgen Inc.
March 21, 2023
From
Robbins LLP
Via
Business Wire
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment'
March 21, 2023
Nvidia on Tuesday demonstrated how its technology is advancing artificial intelligence in myriad industries. Nvidia stock has soared in 2023.
Via
Investor's Business Daily
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
March 21, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
These Are The Top 3 Large Caps For Yield And Dividend Growth
March 21, 2023
You can use Marketbeat's Dividend Screener to find top dividend growth stocks with yields above 3% and value for investors.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
March 20, 2023
These businesses are performing much better than their stock prices would suggest.
Via
The Motley Fool
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)
March 20, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Amgen Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
March 19, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Regulatory Compliance
Exposures
Financial
Legal
Regulatory
AMGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Securities Class Action Lawsuit Against Amgen Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
March 18, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, Credit Suisse, SVB, and Amgen and Encourages Investors to Contact the Firm
March 17, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate
March 17, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Attention Amgen Inc. (AMGN) Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Amgen Inc. and Encourages Investors with Significant Losses to Contact the Firm
March 16, 2023
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
48
49
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.